Vivo Capital’s BlossomHill Therapeutics BLSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.8M Buy
+1,493,740
New +$29.7M 3.06% 13

Other funds holding BLSM

Vivo Capital's BLSM Position: Q3 2026 in Review

Vivo Capital opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 1,493,740 shares worth $27.8M. The stake represents 3.06% of the portfolio and ranks #13 among its holdings.

39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.

  • Vivo Capital held 1,493,740 shares of BlossomHill Therapeutics worth $27.8M as of Q3 2026.
  • BlossomHill Therapeutics was a new Vivo Capital position in Q3 2026.
  • BlossomHill Therapeutics made up 3.06% of Vivo Capital's portfolio in Q3 2026, its #13 holding.
  • 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.

Based on Vivo Capital's 13F filing for Q3 2026, filed 13 Nov 2026.